[Closure of postoperative anastomotic fistulas with a somatostatin analogue]
- PMID: 1937211
[Closure of postoperative anastomotic fistulas with a somatostatin analogue]
Abstract
Postoperative gastrointestinal fistula formation is not rare, and is accompanied by considerable morbidity and mortality. Somatostatin, a potential, universal endocrine and exocrine inhibitor, is a peptide synthesized in the nervous system and the gastrointestinal tract. We describe 2 men, 58 and 53 years old, respectively, with postoperative fistulas, the first after pancreatic-jejunal and the second after jejunal anastomosis. 7 and 3 days, respectively, after starting a synthetic somatostatin analogue (SMS 201-995), discharge from the fistulas decreased and they closed completely.
Similar articles
-
[Use of somatostatin analogue for intestinal and pancreatic fistulas].Harefuah. 1991 Feb 15;120(4):185-6. Harefuah. 1991. PMID: 2066018 Hebrew.
-
Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.Dig Dis. 1994 Jan-Feb;12(1):62-8. doi: 10.1159/000171437. Dig Dis. 1994. PMID: 8200125
-
[Gastrointestinal fistulas. Treatment with a somatostatin analogue (SMS 201-995)].G E N. 1994 Oct-Dec;48(4):209-18. G E N. 1994. PMID: 7557275 Review. Spanish.
-
Treatment of high output enterocutaneous fistulas with a somatostatin analogue and famotidine.Eur J Surg. 1992 Aug;158(8):443-5. Eur J Surg. 1992. PMID: 1356486 No abstract available.
-
Somatostatin treatment of gastrointestinal fistulae.Ann Chir Gynaecol. 1989;78(2):124-6. Ann Chir Gynaecol. 1989. PMID: 2572196 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical